News
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
The White House is withdrawing the nomination of former Fox News medical contributor Janette Nesheiwat for U.S. surgeon ...
The Trump administration is “basically taking ‘move fast and break things’ and applying it to our nation’s medical research ...
Since launching four years ago with industry backing, the AMR Action Fund has closed on 10 investments for antibiotics and ...
Attorney General Pam Bondi's claim that fentanyl seizures saved 258 million lives follows a long line of dubious claims from ...
Vinay Prasad, a skeptic of mainstream medicine, is now a top FDA official. Change is coming for some drugmakers, one way or ...
The meeting was with a startup created by Flatiron Health veterans Josh Haimson and Ben Birnbaum. The duo had built the first ...
Trump cuts are hitting the National Cancer Institute, affecting a hotline for patients, cancer.gov, advisory panels, clinical ...
Advances in AI, genomics, and liquid biopsy are reshaping cancer care, but systemic gaps persist in access and funding, ...
No amount of data showing that RFK Jr. is wrong will change his mind,” vaccine advocate Paul Offit writes in an open letter ...
Vinay Prasad, an academic and fierce critic of the medical mainstream, has been chosen to be the next director of the FDA ...
“Potential exposure to these substances is still quite small, thank goodness,” Jim Crotty, who served for over a decade in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results